Cholestatic liver fibrosis and toxin-induced fibrosis are exacerbated in matrix metalloproteinase-2 deficient mice

Biochemical and Biophysical Research Communications

Volumn 406, Issue 1, 2011, Pages 134-140

  Onozuka, Izumi ^a   Kakinuma, Sei ^a   Kamiya, Akihide ^b   Miyoshi, Masato ^a   Sakamoto, Naoya ^a   Kiyohashi, Kei ^a   Watanabe, Takako ^a   Funaoka, Yusuke ^a   Ueyama, Mayumi ^a   Nakagawa, Mina ^a   Koshikawa, Naohiko ^b   Seiki, Motoharu ^b   Nakauchi, Hiromitsu ^b   Watanabe, Mamoru ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Bile duct ligation; Carbon tetrachloride; PDGF receptor; TGF ; TIMP1

Indexed keywords

CARBON TETRACHLORIDE; GELATINASE A; MATRIX METALLOPROTEINASE 14; METALLOPROTEINASE INHIBITOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BILE DUCT LIGATION; CELL ACTIVATION; CHOLESTASIS; CHOLESTATIC LIVER FIBROSIS; CONTROLLED STUDY; DISEASE EXACERBATION; ENZYME DEFICIENCY; FEMALE; LIVER CELL; LIVER FIBROSIS; NONHUMAN; PRIORITY JOURNAL; RAT; STELLATE CELL; UPREGULATION;

ACTINS; ANIMALS; CARBON TETRACHLORIDE; CHOLESTASIS; COLLAGEN TYPE I; DISEASE PROGRESSION; LIVER CIRRHOSIS; MATRIX METALLOPROTEINASE 2; MICE; MICE, KNOCKOUT; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

MURINAE; MUS;

EID: 79952185704     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.02.012     Document Type: Article

References (23)

1. Hemmann S., Graf J., Roderfeld M., et al. Expression of MMPs and TIMPs in liver fibrosis - a systematic review with special emphasis on anti-fibrotic strategies. J. Hepatol. 2007, 46:955-975.
2. Seiki M. The cell surface: the stage for matrix metalloproteinase regulation of migration. Curr. Opin. Cell Biol. 2002, 14:624-632.
3. Friedman S.L. Evolving challenges in hepatic fibrosis. Nat. Rev. Gastroenterol. Hepatol. 2010, 7:425-436.
4. Lichtinghagen R., Bahr M.J., Wehmeier M., et al. Expression and coordinated regulation of matrix metalloproteinases in chronic hepatitis C and hepatitis C virus-induced liver cirrhosis. Clin. Sci. 2003, 105:373-382.
5. Takahara T., Furui K., Funaki J., et al. Increased expression of matrix metalloproteinase-II in experimental liver fibrosis in rats. Hepatology 1995, 21:787-795.
6. Kossakowska A.E., Edwards D.R., Lee S.S., et al. Altered balance between matrix metalloproteinases and their inhibitors in experimental biliary fibrosis. Am. J. Pathol. 1998, 153:1895-1902.
7. Watanabe T., Niioka M., Ishikawa A., et al. Dynamic change of cells expressing MMP-2 mRNA and MT1-MMP mRNA in the recovery from liver fibrosis in the rat. J. Hepatol. 2001, 35:465-473.
8. Uchinami H., Seki E., Brenner D.A., et al. Loss of MMP 13 attenuates murine hepatic injury and fibrosis during cholestasis. Hepatology 2006, 44:420-429.
9. Seiki M., Koshikawa N., Yana I. Role of pericellular proteolysis by membrane-type 1 matrix metalloproteinase in cancer invasion and angiogenesis. Cancer Metastasis Rev. 2003, 22:129-143.
10. Issa R., Zhou X., Constandinou C.M., et al. Spontaneous recovery from micronodular cirrhosis: evidence for incomplete resolution associated with matrix cross-linking. Gastroenterology 2004, 126:1795-1808.
11. Osawa Y., Hannun Y.A., Proia R.L., et al. Roles of AKT and sphingosine kinase in the antiapoptotic effects of bile duct ligation in mouse liver. Hepatology 2005, 42:1320-1328.
12. Itoh T., Ikeda T., Gomi H., et al. Unaltered secretion of beta-amyloid precursor protein in gelatinase A (matrix metalloproteinase 2)-deficient mice. J. Biol. Chem. 1997, 272:22389-22392.
13. Opie E.L., Rothbard M.B. Osmotic homeostasis maintained by mammalian liver, kidney, and other tissues. J. Exp. Med. 1953, 97:483-497.
14. Kakinuma S., Ohta H., Kamiya A., et al. Analyses of cell surface molecules on hepatic stem/progenitor cells in mouse fetal liver. J. Hepatol. 2009, 51:127-138.
15. Kakinuma S., Tanaka Y., Chinzei R., et al. Human umbilical cord blood as a source of transplantable hepatic progenitor cells. Stem Cells 2003, 21:217-227.
16. Dranoff J.A., Wells R.G. Portal fibroblasts: underappreciated mediators of biliary fibrosis. Hepatology 2010, 51:1438-1444.
17. Li Z., Dranoff J.A., Chan E.P., et al. Transforming growth factor-beta and substrate stiffness regulate portal fibroblast activation in culture. Hepatology 2007, 46:1246-1256.
18. Kinnman N., Francoz C., Barbu V., et al. The myofibroblastic conversion of peribiliary fibrogenic cells distinct from hepatic stellate cells is stimulated by platelet-derived growth factor during liver fibrogenesis. Lab. Invest. 2003, 83:163-173.
19. Vaillant B., Chiaramonte M.G., Cheever A.W., et al. Regulation of hepatic fibrosis and extracellular matrix genes by the response: new insight into the role of tissue inhibitors of matrix metalloproteinases. J. Immunol. 2001, 167:7017-7026.
20. Wake K. " Sternzellen" in the liver: perisinusoidal cells with special reference to storage of vitamin A. Am. J. Anat. 1971, 132:429-462.
21. Roeb E., Purucker E., Breuer B., et al. TIMP expression in toxic and cholestatic liver injury in rat. J. Hepatol. 1997, 27:535-544.
22. Radbill B.D., Gupta R., Ramirez M.C., et al. Loss of matrix metalloproteinase-2 amplifies murine toxin-induced liver fibrosis by upregulating collagen I expression. Dig. Dis. Sci. 2011, 56:406-416.
23. Madala S.K., Pesce J.T., Ramalingam T.R., et al. Matrix metalloproteinase 12-deficiency augments extracellular matrix degrading metalloproteinases and attenuates IL-13-dependent fibrosis. J. Immunol. 2010, 184:3955-3963.